An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Cesaro, Annabelle ^a   Anceriz, Nadia ^a   Plante, Audrey ^a   Pagé, Nathalie ^a   Tardif, Mélanie R ^a   Tessier, Philippe A ^a  

^a Université Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CALGRANULIN B; COLLAGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CARTILAGE DEGENERATION; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MONOCYTE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; BONE AND BONES; CALGRANULIN B; CARTILAGE; CELL ADHESION; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTE L1 ANTIGEN COMPLEX; MICE; MONOCYTES; NEUTROPHILS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 84866518559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045478     Document Type: Article

References (51)

1. Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, et al. (1997) Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 107: 507-512.
2. Schrier DJ, Schimmer RC, Flory CM, Tung DK, Ward PA, (1998) Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J Leukoc Biol 63: 359-363.
3. Marie I, Guglielmino E, (2010) [Non tuberculous anti-TNF associated opportunistic infections]. Rev Med Interne 31: 353-360.
4. Miller EA, Ernst JD, (2009) Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J Clin Invest 119: 1079-1082.
5. Prinz JC (2011) Autoimmune-like syndromes during TNF blockade: does infection have a role? Nat Rev Rheumatol.
6. Alves JD, Marinho A, Serra MJ, (2011) Tocilizumab: is there life beyond anti-TNF blockade? Int J Clin Pract 65: 508-513.
7. Nacken W, Roth J, Sorg C, Kerkhoff C, (2003) S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60: 569-580.
8. Berntzen HB, Olmez U, Fagerhol MK, Munthe E, (1991) The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 20: 74-82.
9. Foell D, Roth J, (2004) Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 50: 3762-3771.
10. Baillet A, Trocme C, Berthier S, Arlotto M, Grange L, et al. (2010) Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) 49: 671-682.
11. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, et al. (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853.
12. Lugering N, Stoll R, Kucharzik T, Schmid KW, Rohlmann G, et al. (1995) Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 56: 406-414.
13. Rouleau P, Vandal K, Ryckman C, Poubelle PE, Boivin A, et al. (2003) The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol 107: 46-54.
14. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, et al. (2003) Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 48: 2310-2320.
15. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N, (1991) Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 266: 7706-7713.
16. Hessian PA, Edgeworth J, Hogg N, (1993) MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 53: 197-204.
17. Eue I, Pietz B, Storck J, Klempt M, Sorg C, (2000) Transendothelial migration of 27E10+ human monocytes. Int Immunol 12: 1593-1604.
18. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, et al. (2000) Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 43: 628-637.
19. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA, (2003) Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 170: 3233-3242.
20. Newton RA, Hogg N, (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160: 1427-1435.
21. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B, (1980) Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666-668.
22. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, et al. (1990) Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 118: 193-232.
23. Youssef P, Roth J, Frosch M, Costello P, Fitzgerald O, et al. (1999) Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 26: 2523-2528.
24. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, et al. (2003) Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171: 2602-2609.
25. Aguiar-Passeti T, Postol E, Sorg C, Mariano M, (1997) Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J Leukoc Biol 62: 852-858.
26. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D, (2006) S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312: 184-197.
27. Hammer HB, Odegard S, Fagerhol MK, Landewe R, van der Heijde D, et al. (2007) Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 66: 1093-1097.
28. Liao H, Wu J, Kuhn E, Chin W, Chang B, et al. (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50: 3792-3803.
29. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, et al. (1987) Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80-82.
30. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, et al. (2006) The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 8: R69.
31. van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, et al. (2008) Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 67: 1750-1758.
32. Rampersad RR, Esserman D, McGinnis MW, Lee DM, Patel DD, et al. (2009) S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritis. Scand J Rheumatol 38: 445-449.
33. Lim SY, Raftery MJ, Geczy CL, (2011) Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. Antioxid Redox Signal 15: 2235-2248.
34. Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, et al. (2004) Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. Oral Microbiol Immunol 19: 182-187.
35. Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, et al. (2004) Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophils. J Leukoc Biol 76: 433-440.
36. Hogg N, Allen C, Edgeworth J, (1989) Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 19: 1053-1061.
37. Robinson MJ, Tessier P, Poulsom R, Hogg N, (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277: 3658-3665.
38. Yu T, Wu X, Gupta KB, Kucik DF, (2010) Affinity, lateral mobility, and clustering contribute independently to beta 2-integrin-mediated adhesion. Am J Physiol Cell Physiol 299: C399-410.
39. Leirisalo-Repo M, (1994) The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 75Suppl 2: 1-3.
40. Klugewitz K, Ley K, Schuppan D, Nuck R, Gaehtgens P, et al. (1997) Activation of the beta2 integrin Mac-1 (CD11b/CD18) by an endogenous lipid mediator of human neutrophils and HL-60 cells. J Cell Sci 110 (Pt 8): 985-990.
41. Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, et al. (2000) IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 12: 187-193.
42. Yoshitake F, Itoh S, Narita H, Ishihara K, Ebisu S, (2008) Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J Biol Chem 283: 11535-11540.
43. Grevers LC, de Vries TJ, Vogl T, Abdollahi-Roodsaz S, Sloetjes AW, et al. (2011) S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: Implications for bone destruction in murine antigen-induced arthritis. Arthritis Rheum 63: 1365-1375.
44. Schelbergen RFPvL, Peter L.; Blom, Arjen B.; Sloetjes, Annet; Vogl, Thomas; Roth, Johannes; Van Den Berg Wim B (2010) Alarmins S100A8 and S100A9 Skew Human Chondrocytes towards a Cartilage Breakdown Phenotype. Annual Scientific Meeting Atlanta, geprgia: Abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals.
45. Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, et al. (2011) TNF/IL-17 interplay induces S100A8, IL-1beta, and MMPs, and drives irreversible cartilage destruction In Vivo: Rationale for combination treatment during arthritis. Arthritis Rheum.
46. Simard JC, Simon MM, Tessier PA, Girard D, (2011) Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol 186: 3622-3631.
47. Nemeth J, Stein I, Haag D, Riehl A, Longerich T, et al. (2009) S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251-1262.
48. Salama I, Malone PS, Mihaimeed F, Jones JL, (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364.
49. Shibata F, Ito A, Ohkuma Y, Mitsui K, (2005) Mitogenic activity of S100A9 (MRP-14). Biol Pharm Bull 28: 2312-2314.
50. Konttinen YT, Li TF, Hukkanen M, Ma J, Xu JW, et al. (2000) Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res 2: 348-355.
51. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16: 713-717.